leisure time -WSS

leisure time

author：comprehensive 2025-09-29 01:35:36 - browse：75478

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Wikipedia

WSS

WATCH: Why do fingernails fall off when they're damaged?

Doctors' information doesn't help them choose wisely when sick

The strategy behind pharma's lawsuits over drug pricing reform

Why are elite athletes different? Take a look at their microbes

Medicare threatens to cut off funding for HCA's Mission hospital

Disclosing genetic information: not as worrisome as once feared

focus

leisure time

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

3 hurdles to bringing medical devices to the U.S. market

New air purifier tech could be key to improving indoor air quality

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

New air purifier tech could be key to improving indoor air quality

What would happen to your eyes if you looked at the solar eclipse?

Heart attack and stroke risk calculators need revising

KalVista pill reduced swelling 'attacks' caused by genetic disease

Medicare details structure of new drug price negotiation program

The dental labor crisis is a moment of opportunity

focus

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

The battle over the Brookhaven Landfill on Long Island

The dental labor crisis is a moment of opportunity

STAT's guide to the next generation of CAR

Biden report: The neurospychology of memory and aging

Key House Republican on health care plans exit from Congress

leisure time

knowledge

Wikipedia

focus